High-sensitivity proteomic analysis services based on dual recognition technologies and next-generation sequencing-type DNA detection (PEA or equivalent), for 172 samples taken from cancer patients | Tenderlake

High-sensitivity proteomic analysis services based on dual recognition technologies and next-generation sequencing-type DNA detection (PEA or equivalent), for 172 samples taken from cancer patients

Contract Value:
RON 113K - 113K
Notice Type:
Contract Notice
Published Date:
21 November 2025
Closing Date:
22 December 2025
Location(s):
RO113 Cluj (RO Romania/ROMÂNIA)
Description:
High-sensitivity proteomic analysis services using dual recognition technologies and next-generation sequencing-type DNA detection are required for samples from lung cancer patients.

High-sensitivity proteomic analysis services based on dual recognition technologies and next-generation sequencing-type DNA detection (PEA or equivalent), for 172 samples taken from lung cancer patients


LOT-0000
Default lot.
High-sensitivity proteomic analysis services based on dual recognition technologies and next-generation sequencing-type DNA detection (PEA or equivalent), for 172 samples taken from lung cancer patients

The Buyer:
Universitatea de Medicina si Farmacie "Iuliu Hatieganu" Cluj-Napoca
Additional information:
Link:
Download Full Notice as PDF
Link:
Additional document: Documentatia de achizitie
Link:
View Full Notice
CPV Code(s):
73110000 - Research services